Disclaimer: Our clinical weight loss program is informed by a retrospective chart review and early program evaluation
Emsley, P., Lohkamp, B., Scott, W
The 8mg dose produced 22.8% average weight loss at 48 weeks in the phase 2 trial, with 100% of participants losing at least 5% and 91% losing at least 10% of body weight
Wait and see if mild reactions go away If your injection site reaction isnt bothering you too much, you dont have to treat it
On the ongoing all-in rate, PlexusDx Semaglutide Injection ($189/mo, no membership) is below Edens $198/mo all-in, and the PlexusDx Microdose GLP-1 Protocol at $129/mo flat is lower still
Vetri Cardio Canine is recommended for support of heart muscle and function, reducing oxidative stress, and improvement in circulation and utilization of oxygen